Internal Medicine Alert – September 15, 2003
September 15, 2003
View Issues
-
Improvement of Gastroesophageal Reflux Symptoms after Radiofrequency Energy
This study demonstrated that the Stretta endoscopic radiofrequency application technique for treatment of gastroesophageal reflux disease did lead to lessened GERD-related symptoms but not to any decrease in esophageal acid exposure or medication use. -
Breast Cancer and HRT: The Million Women Study
Current users of estrogen or estrogen-progestin combinations were shown to have a significantly higher risk of developing and dying from breast cancer. The findings confirm and extend those published last year by the Womens Health Initiative. -
Fish Story or Food for Thought?
Dietary intake of n-3 fatty acids and weekly consumption of fish may reduce the risk of incident Alzheimers disease. -
Doctor, I’m Dizzy!
Dizziness and vertigo are among the most common complaints seen by neurologists, and benign paroxysmal positional vertigo is one of their most frequent causes. -
Pharmacology Update: Testosterone Buccal System (Striant)
The FDA has approved the first transbuccal delivery system for testosterone replacement therapy in men. -
Clinical Briefs
Urinary Tetrahydroaldosterone as a Screen for Primary Aldosteronism; Finasteride and Prostate Cancer; Impermeable Bed Covers in Patients with Allergic Rhinitis -
ECG Review: Concealing the Cause
The 12-lead ECG and accompanying rhythm strip in the Figure were obtained from an asymptomatic and otherwise healthy 53-year-old man. What two things are unusual about the beat marked X? Did first degree AV block suddenly develop for the following sinus-conducted beat (beat Y)? -
Pharmacology Watch: Study Shows Oral IIb/IIIa Receptors Increase Mortality
Another study has shown an increase in mortality associated with the use of an oral IIb/IIIa receptor antagonist.